Cargando…

Disadvantages of photodynamic therapy for polypoidal choroidal vasculopathy

Detalles Bibliográficos
Autor principal:	Chhablani, Jay Kumar
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Letters to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994002/ https://www.ncbi.nlm.nih.gov/pubmed/20952852 http://dx.doi.org/10.4103/0301-4738.71691

Ejemplares similares

Anti-vascular endothelial growth factor drugs in polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar
Publicado: (2011)

Intravitreal bevacizumab monotherapy for treatment-naive polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar, et al.
Publicado: (2014)

Intravitreal bevacizumab monotherapy for treatment-naïve polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar, et al.
Publicado: (2013)

Author reply to comment on photodynamic therapy and polypoidal choroidal vasculopathy
por: Williams, Gwyn Samuel, et al.
Publicado: (2014)

Photodynamic therapy for polypoidal choroidal vasculopathy secondary to choroidal nevus
por: Wong, James G, et al.
Publicado: (2017)

Pachydrusen in polypoidal choroidal vasculopathy in an Indian cohort
por: Singh, Sumit Randhir, et al.
Publicado: (2019)

Aggravation of polypoidal choroidal vasculopathy after cataract surgery
por: Kim, Moosang, et al.
Publicado: (2012)

Treatment of polypoidal choroidal vasculopathy with intravitreal bevacizumab monotherapy
por: Tan, Colin S H, et al.
Publicado: (2013)

Update: Juxtapapillary choroidal excavation with polypoidal choroidal vasculopathy - An unusual association
por: Chowdhury, Maitreyi, et al.
Publicado: (2019)

Treatment of polypoidal choroidal vasculopathy by photodynamic therapy, aflibercept and dexamethasone triple therapy
por: Ho, Mary, et al.
Publicado: (2016)

Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization
por: Chhablani, Jay Kumar
Publicado: (2010)

Submacular hemorrhage from polypoidal choroidal vasculopathy after cataract surgery
por: Tan, Colin S H, et al.
Publicado: (2013)

Long-Term Prognosis of Patients with Polypoidal Choroidal Vasculopathy Treated with Photodynamic Therapy
por: Sakaeda, Yukinori, et al.
Publicado: (2023)

Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy
por: Singh, Sumit Randhir, et al.
Publicado: (2019)

Latest Developments in Polypoidal Choroidal Vasculopathy: Epidemiology, Etiology, Diagnosis, and Treatment
por: Chaikitmongkol, Voraporn, et al.
Publicado: (2020)

Polypoidal Choroidal Vasculopathy in Asians
por: Wong, Chee Wai, et al.
Publicado: (2015)

Comparison of intravitreal bevacizumab to photodynamic therapy for polypoidal choroidal vasculopathy: Short-term results
por: Mitamura, Yoshinori, et al.
Publicado: (2010)

Two-year follow-up of ranibizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy
por: Nemoto, Rei, et al.
Publicado: (2012)

Efficacy of Initial vs. Delayed Photodynamic Therapy in Combination With Conbercept for Polypoidal Choroidal Vasculopathy
por: Sun, Zuhua, et al.
Publicado: (2022)

Combined photodynamic therapy and intravitreal ranibizumab as treatment for extrafoveal choroidal neovascularization associated with age-related macular degeneration
por: Chhablani, Jay Kumar
Publicado: (2010)

Comment on: Aflibercept for recurrent or recalcitrant polypoidal choroidal vasculopathy in Indian eyes: Early experience
por: Kathiriya, Vidhi, et al.
Publicado: (2018)

One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy
por: Weng, Hsin-Yu, et al.
Publicado: (2019)

Choroidal Nevus in an Eye with Polypoidal Choroidal Vasculopathy
por: Asao, Kazunobu, et al.
Publicado: (2014)

Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India
por: Sheth, Jay U, et al.
Publicado: (2022)

Reply to comment on: Aflibercept for recurrent or recalcitrant polypoidal choroidal vasculopathy in Indian eyes: Early experience
por: Bansal, Aditya, et al.
Publicado: (2018)

Polypoidal choroidal vasculopathy: Pearls in diagnosis and management
por: Anantharaman, Giridhar, et al.
Publicado: (2018)

1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy
por: Wong, Ian Y., et al.
Publicado: (2015)

Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathy
por: Kikushima, Wataru, et al.
Publicado: (2017)

Comparing efficacy of reduced-fluence and standard-fluence photodynamic therapy in the treatment of polypoidal choroidal vasculopathy
por: Ngo, Wei Kiong, et al.
Publicado: (2020)

Corrigendum: Efficacy of Initial vs. Delayed Photodynamic Therapy in Combination With Conbercept for Polypoidal Choroidal Vasculopathy
por: Sun, Zuhua, et al.
Publicado: (2022)

Comparison of the 2-Year Results of Photodynamic Therapy with Aflibercept and Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy
por: Miyakubo, Tomoko, et al.
Publicado: (2023)

Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy
por: Kapoor, Kapil G., et al.
Publicado: (2015)

Polypoidal Choroidal Vasculopathy in Congolese Patients
por: Kabedi, Nelly N., et al.
Publicado: (2020)

Regression in polypoidal choroidal vasculopathy treated with ziv-aflibercept monotherapy – short term study
por: Mishra, Sai B., et al.
Publicado: (2022)

Immediate onset of sterile endophthalmitis with hypopyon after intravitreal Brolucizumab in a case of polypoidal choroidal vasculopathy
por: Narayanan, Raja, et al.
Publicado: (2021)

Evolution of Polypoidal Lesions after Treatment of Polypoidal Choroidal Vasculopathy
por: Tan, Colin S., et al.
Publicado: (2021)

One-Year Outcome of Aflibercept and Photodynamic Therapy in a Caucasian Patient with Polypoidal Choroidal Vasculopathy Refractory to Ranibizumab and Photodynamic Therapy
por: Medina-Baena, Marta, et al.
Publicado: (2018)

Combined photodynamic therapy and intravitreal bevacizumab for idiopathic polypoidal choroidal vasculopathy: one-year follow-up
por: Romano, Mario R, et al.
Publicado: (2010)

One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy
por: Sakurai, Madoka, et al.
Publicado: (2014)

Positive association of CD36 gene variants with the visual outcome of photodynamic therapy in polypoidal choroidal vasculopathy
por: Honda, Shigeru, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_sb40lofp48clrg8p17io9vaqcu